Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis [5]

Annals of the Rheumatic Diseases

Volumn 62, Issue 7, 2003, Pages 685-

  Bridges, M J ^a,c   Coady, D ^b   Kelly, C A ^a   Hamilton, J ^a   Heycock, C ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; INFLUENZA VACCINE; METHOTREXATE;

AWARENESS; CONFIDENCE INTERVAL; DRUG UPTAKE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; ISCHEMIC HEART DISEASE; LETTER; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; GUIDELINE ADHERENCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; MALE; METHOTREXATE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 0037532693     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.7.685     Document Type: Letter

References (1)

1. BSR. National guidelines for the monitoring of second line drugs. London: British Society for Rheumatology, 2000.